is mounjaro a glp-1 agonist glp 1 drug Mounjaro Tirzepatide Gip Receptor Stock Photo 2453657649 Holding GLP-1 Agonists Prior to
Description
Dipeptidyl peptidase-4 inhibitor use is associated with decreased risk of fracture in patients with type 2 diabetes: a population-based cohort study
C/EBP, CCAAT/enhancer binding protein
Since gastrointestinal adverse effects are rarely severe and tend to diminish over time, they would therefore not be expected to cause a barrier to initiating and continuing treatment for most patients
[DOI] [PMC free article] [PubMed] [Google Scholar] 212.Phuwamongkolwiwat P., et al
The 2014 study by Phuwamongkolwiwat et al
Available from: 10 Goldman Sachs, 2023
